TrialJournal of atherosclerosis and thrombosis2026

Pemafibrate Increases Circulating Angiopoietin-like Proteins 3 and 4 Without Promoting Pro-Atherogenic Changes in LDL and HDL Subspecies: A Post-Hoc Analysis of the PRESTIGE Study.

Tsutomu Hirano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.